期刊文献+

异丙酚对2型糖尿病患者冠状动脉旁路移植术前与术后心肌损伤程度及其心功能的影响 被引量:5

Effect of propofol intravenous on myocardial damage degree and cardiac function for 2 diabetes patients before and after coronary artery bypass grafting
原文传递
导出
摘要 目的研究异丙酚对2型糖尿病患者冠状动脉旁路移植术(CABG)前后心肌损伤程度和心功能的影响。方法入选76例2型糖尿病患者,根据随机数字法分为试验组和对照组,每组38例。2组患者均采取常规麻醉诱导后,试验组以输注异丙酚1~2μg·kg^(-1)·m L^(-1)维持麻醉,同时持续静脉输注0.2~0.4μg·kg^(-1)·min^(-1)瑞芬太尼;对照组吸入异氟烷和静脉输注0.2~0.4μg·kg^(-1)·min^(-1)瑞芬太尼。于手术前和术后12 h,测定2组患者的丙二醛(MDA)、超氧化物歧化酶(SOD)、缺血修饰白蛋白(IMA)及肌钙蛋白I(c Tn I)水平。结果手术前,与对照组的MDA、SOD、IMA、c Tn I水平分别为(3.62±0.37)nmol·L^(-1)、(72.36±8.22)nmol·L^(-1)、(77.61±3.74)ABSU·m L^(-1)、(0.07±0.01)μg·L^(-1)比较,试验组的这4个指标水平分别为(3.69±0.43)nmol·L^(-1)、(73.24±6.13)nmol·L^(-1)、(77.29±3.94)ABSU·m L^(-1)、(0.08±0.02)μg·L^(-1),2组差异无统计学意义(P>0.05)。手术后12 h,试验组的MDA、IMA及c Tn I水平分别为(4.42±0.82)nmol·L^(-1)、(70.52±2.62)ABSU·m L^(-1)、(3.70±0.28)μg·L^(-1),显著低于对照组的(7.14±1.01)nmol·L^(-1)、(73.63±4.12)ABSU·m L^(-1)、(4.79±0.29)μg·L^(-1);而试验组SOD为(68.74±6.82)nmol·L^(-1),显著高于对照组的(64.01±5.88)nmol·L^(-1),2组差异均有统计学意义(均P<0.05)。结论在2型糖尿病患者中进行CABG手术时,相对于异氟烷,使用静脉麻醉药异丙酚能有效降低患者心肌损伤程度,更能有效地保护心功能。 Objective To study the effect of propofol intravenous on myocardial damage degree and cardiac function for 2 diabetes patients before and after coronary artery bypass grafting. Methods Seventy - six patients with type 2 diabetes in our hospital was selected from April 2014 to October 2015. The patients were divided into treatment group and control group, according to the method of random numbers,38 cases in each group. Patients in two groups were taken general anesthesia induction, treatment group were infused 1 -2μg·kg^-1·min^-1 propofol after anes- thesia induction to maintain anesthesia, continuous intravenous infusion of 0.2 - 0.4μg·kg^-1·min^-1 fentanyl. Patients in control group isoflu- rane inhalation and intravenous 0.2 -0.4 μg·kg^-1·min^-1 fentanyl. Before surgery and postoperative 12 h, the level of the malondialdehyde (MDA), superoxide dismutase (SOD), isehemia modified albumin ( IMA), troponin [ (cardiac troponin I, cTnI) in two groups were measured by spectrophotometer . Results Before the operation, the level of MDA, SOD, IMA, cTnIin the treatment group were (3.69 ±0.43) nmol·L^-1, (73.24 ±6.13) nmol·L^-1, (77.29± 3.94) ABSU·mL^-1, ( 0. 08 ± 0. 02 ) μg· L^-1, respectively while in control group were ( 3.62 ± 0. 37 ) nmol·L^-1, (72.36 ±8.22) nmol·L^-1 , (77.61 ± 3.74) ABSU·mL^-1 , (0.07 ± 0.01 ) μg·L^-1 with no significant difference (P〉0.05). After 12 h of operation , the level of MDA, IMA, cTnI in treatment group were (4.42 ± 0.82) nmol· L^-1, (70. 52 ± 2. 62) ABSU· mL^-1, ( 3.70 ± 0. 28 ) μg· L^-1, significantly lower than control group with (7. 14 ± 1.01 ) nmol·L^-1, (73.63 ± 4. 12 ) ABSU·mL^-1, (4. 79 ± 0. 29 )μg ·L^-1. But SOD in treatment group was ( 68.74 ± 6. 82) nmol· L^-1, significantly higher than the control group with ( 64. 01±5.88 ) nmol·L^-1, the difference between two groups above factors had statistical significance (all P 〈 0. 05 ) . Conclusion Patients with type 2 diabetes using CABG surgery, the use of intravenous propofol, compared with isoflurane, can effectively reduce the degree of myocardial injury and effectively protect the cardiac function in patients.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2017年第10期867-869,876,共4页 The Chinese Journal of Clinical Pharmacology
基金 山西省卫生厅科技攻关计划项目青年基金资助项目(20100103) 山西省科技厅社会发展基金资助项目(20130313021-13)
关键词 异丙酚 2型糖尿病 冠状动脉旁路移植术 心肌损伤程度 心功能 propofol type 2 diabetes coronary artery bypass grafting myocardial damage degree cardiac function
  • 相关文献

参考文献7

二级参考文献61

  • 1关开华,卢寒冬,黄雄庆.麻醉对围手术期应激反应的影响研究[J].医学信息(医学与计算机应用),2014,0(6):537-538. 被引量:9
  • 2陆国平,吴志俊,戚文航.他汀类药物与动脉粥样硬化斑块消退[J].中国循环杂志,2007,22(1):69-72. 被引量:25
  • 3CHEN Li-ying ZHU Wen-hua CHEN Zhou-wen DAI Hong-lei REN Jing-jing CHEN Jian-hua CHEN Lei-qian FANG Li-zheng.Relationship between hyperuricemia and metabolic syndrome[J].Journal of Zhejiang University-Science B(Biomedicine & Biotechnology),2007,8(8):593-598. 被引量:54
  • 4Ford ES,Ajani UA,Croft JB,et al. Explaining the decrease in U. S.deaths from coronary disease, 1980-2000. N Engl J Med, 2007,356 ( 23 ) :2388-2398.
  • 5Morgan TM, Krumholz HM, Lifton RP, et al. Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale repli- cation study. JAMA,2007,297(14) :1551-1561.
  • 6Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study) : case-control study. Lancet,2004,364 ( 9438 ) : 937-952.
  • 7Clendenning R. The optimal low-density lipoprotein is 50 to 70 mg/dl [ letter. J Am Coll Cardio1,2005,45 (10) : 1732.
  • 8Reardon MF, Nestel PJ, Craig IH, et al. Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation, 1985,71 (5) :881-888.
  • 9Sullivan DR, Marwick TH, Freedman SB. A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J, 1990, 119: 1262-1267.
  • 10Yusuf S, Reddy S, Ounpuu S, et al. Global burden of cardiovascular diseases,part I general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation, 2001,104 ( 22 ) : 2746-2753.

共引文献426

同被引文献37

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部